Excretion into bile is well recognized as a major pathway for the elimination of amphipathic, hydrophobic, high molecular weight xenobiotics and thus complements the renal elimination of hydrophilic compounds of low molecular weight. For many xenobiotics, excretion in bile, which has been termed a phase III elimination reaction (1) , begins with an oxidation reaction (phase I), followed by conjugation ( (2) . In an elegant series of studies, Rickert and colleagues suggested a bioactivation pathway involving hepatic metabolism to dinitrobenzyl glucuronide followed by biliary excretion, deconjugation, and nitroreduction by intestinal microflora, and finally reabsorption of the resulting aminonitrobenzyl alcohol, which was then oxidized to reactive metabolites which were genotoxic. A key rate-determining step in the development of hepatocarcinoma was the rate and extent to which the glucuronide conjugate was delivered to the microflora in the gastrointestinal tract, which was several-fold lower in female rats.
Why is biliary excretion of this substrate lower in female rats? Based on the decreased biliary excretion of many substrates during pregnancy, and following treatment with estradiol, ethinyl estradiol, or diethylstilbestrol, it seems most likely that estrogens are important regulators of phase III elimination. The mechanism by which estrogens inhibit this process is not known, but the selective changes induced by treatment of rats with ethinyl estradiol (i.e., inhibition of some transporters; ATP-dependent transport of bile acids) but stimulation of others (Na+/glycine cotransport) in rat canalicular membrane vesicles suggest estrogen-receptor-mediated events, rather than a generalized "toxic" response (3, 4) .
Are environmental estrogens (e.g., chlordecone, DDT) able to interact with hepatic estrogen receptors and simulate the inhibitory effects of classic estrogens on biliary excretion? Interestingly, the biliary excretion of several substrates is increased postpartum in lactating rats; this effect has recently been shown to be mediated by the anterior pituitary hormone prolactin (5 of glutathione conjugates following their excretion into bile. The nephron bile begin with oxidation in the toxicity of cysteine-S conjugates is gation (phase 11).
well-known (6), and has been shown to require formation of an S-glutathione conjugate in the liver, followed by secretion into bile. The ectoenzymes, gamma-glutamyltransferase (GGT) and dipeptidases are then able to catalyze its hydrolysis to cysteine-S conjugates. The high concentrations of GGT in the intestine and kidney relative to the liver led initially to the concept that these organs were required for formation of cysteine-S conjugates. Ballatori and colleagues (7) have shown that this may be true for the rat and mouse, which have very low levels of hepatic GGT, but is unlikely for species like the guinea pig and man, which have relatively high concentrations of GGT in the biliary tree. In the guinea pig, glutathione conjugates are readily hydrolyzed within the biliary tree to the cysteine-S conjugates which can then be reabsorbed from the bile back into the liver. This GGTdependent biliary-hepatic recycling has been shown to contribute to the long biologic half-life and toxicity of methyl mercury. Methyl mercury is thought to be transported into bile across the canalicular membrane as a glutathione complex which is hydrolyzed by GGT and dipeptidases to the relatively lipid-soluble methyl mercury-cysteine complex (8) . Changes in the activity of hepatic GGT could therefore influence the retention and thus the toxicity of methyl mercury. What regulates GGT activity, and is this influence by environmental factors? Lieberman and colleagues (9) 
